Phase 3 Rhythm Clinical Trials
7 recruitingPhase 3
What is a Phase 3 trial?
Phase 3 trials compare the new treatment against the current standard of care in large groups, often hundreds to thousands of participants. Successful Phase 3 results are typically required for regulatory approval.
Showing 1–7 of 7 trials
Recruiting
Phase 2Phase 3
Withdrawal of Treatment for Heart Failure Patients With Recovery From Tachycardia-induced Cardiomyopathy
Heart Failure With Reduced Ejection FractionHeart Rhythm Disorder
Herlev and Gentofte Hospital348 enrolled1 locationNCT06128980
Recruiting
Phase 3
Prophylactic Anti-aRrhythmic Therapy With Amiodarone in Critically Ill Patients Admitted for an Out-of-hospital Cardiac Arrest With Initial Shockable Rhythm
Ventricular Arrhythmias and Cardiac Arrest
Versailles Hospital674 enrolled29 locationsNCT06835491
Recruiting
Phase 3
Study Evaluating Dexmedetomidine in the Acute Treatment of Electrical Storm
Ventricular arrhythmiasVentricular TachycardiaVentricular Fibrillation+1 more
Ottawa Heart Institute Research Corporation192 enrolled1 locationNCT06281977
Recruiting
Phase 3
Evaluating the Effects of Tasimelteon vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD)
Sleep Wake DisordersSleep Disorders, Circadian RhythmChronobiology Disorders
Vanda Pharmaceuticals70 enrolled17 locationsNCT04652882
Recruiting
Phase 3
Effect and Safety of Flecainide and Metoprolol Versus Metoprolol Alone to Suppress Ventricular Arrhythmias in Arrhythmic Mitral Valve Prolapse
Mitral valve prolapseVentricular Arrhythmias and Cardiac Arrest
Oslo University Hospital50 enrolled1 locationNCT05631730
Recruiting
Phase 3
Colchicine After Electrocardioversion for Atrial Fibrillation
Atrial FibrillationCardiac Arrhythmia
University Hospital, Basel, Switzerland416 enrolled8 locationsNCT05890664
Recruiting
Phase 3
Evaluating the Effects of Tasimelteon Vs. Placebo in Delayed Sleep-Wake Phase Disorder (DSWPD) and the CRY1Δ11 Variant
Sleep Wake DisordersSleep Disorders, Circadian RhythmChronobiology Disorders+1 more
Vanda Pharmaceuticals60 enrolled1 locationNCT06701396